![](/img/cover-not-exists.png)
PDB21 COST-EFFECTIVENESS ANALYSIS OF BASAL/BOLUS THERAPY IN TYPE-1 DIABETES USING INSULIN DETEMIR + INSULIN ASPART OR HUMAN SOLUBLE INSULIN-BASED BASAL/BOLUS REGIMENS IN GERMANY
WJ Valentine, KU Wittrup-Jensen, AJ Palmer, S RozeVolume:
8
Year:
2005
Language:
english
DOI:
10.1016/s1098-3015(10)67640-1
File:
PDF, 83 KB
english, 2005